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Abstract
Analysis of Schwann cell (SC) development has been hampered by the lack of growing axons in many commonly used in
vitro assays. As a consequence, the molecular signals and cellular dynamics of SC development along peripheral axons are
still only poorly understood. Here we use a superior cervical ganglion (SCG) explant assay, in which axons elongate after
treatment with nerve growth factor (NGF). Migration as well as proliferation and apoptosis of endogenous SCG-derived SCs
along sympathetic axons were studied in these cultures using pharmacological interference and time-lapse imaging.
Inhibition of ErbB receptor tyrosine kinases leads to reduced SC proliferation, increased apoptosis and thereby severely
interfered with SC migration to distal axonal sections and colonization of axons. Furthermore we demonstrate that SC
colonization of axons is also strongly impaired in a specific null mutant of an ErbB receptor ligand, Neuregulin 1 (NRG1) type
III. Taken together, using a novel SC development assay, we demonstrate that NRG1 type III serves as a critical axonal signal
for glial ErbB receptors that drives SC development along sympathetic axons.
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Introduction
Schwann cells (SC), the main glial cell type of the peripheral
nervous system, are derivatives of the neural crest, a transient
structure emerging from the dorsal neural tube [1,2]. Normal SC
function is essential for the development and long term integrity of
peripheral nerves. The number of SCs in peripheral nerves is
adjusted to the number of axons, regulated by proliferation as well
as apoptosis of SC precursors. Several factors have been identified
that influence proliferation and survival of SCs as well as SC
myelination, including TGF-beta [3] and Neuregulin (NRG) 1
[4,5,6,7]. In contrast however, the molecular signals that control
SC precursor migration along nerve fibers are not well
understood. It is presumed that SC precursors originate from a
pool of migrating neural crest cells which move to nerve trunks of
developing efferent and afferent fibers and migrate along these
fibers to ensheath the nerve [8]. NRG1 might influence SC
migration, as demonstrated for rat SCs [9,10] and also for a
conditionally immortalized SC precursor cell line [11]. Genetic
screens in zebrafish have revealed that ErbB2 and ErbB3, which
serve as glial tyrosine kinase receptors for NRG1 in the PNS [12]
are essential for SC migration along the zebrafish lateral line organ
[13]. However, the molecular processes regulating development in
zebrafish may not fully recapitulate those in mammals and analysis
of SC migration in mammals is hampered by the inaccessibility of
peripheral nervous tissues, such as the sciatic nerve or the
sympathetic ganglia for time-lapse imaging in vivo. As a
consequence artificial in vitro assays such as the ‘‘Scratch Assay’’
or the ‘‘Boyden Assay’’ are frequently used to address SC
migration during development. Although these systems provide
the opportunity to obtain quantitative data, they miss two
important features. First, they lack axons the substrate along
which SC migrate physiologically, and second, they normally do
not address proliferation and apoptosis. In this investigation we
took advantage of the ganglion explantation technique [14]. Only
few studies have used a similar approach to analyze SC
development [9,15]. Using growing axons from explanted SCGs
in combination with time-lapse imaging we studied the molecular
processes involved in SC migration, proliferation and cell death
along developing sympathetic axons.
Materials and Methods
Ethics Statement
All animal work was carried out in agreement with the local
ethical committees. The University of Heidelberg/Regierung-
spra ¨sidium Karlsruhe Referat 35 has approved this study (ID: T-
07/10 and T-59/08).’’
Collagen gel preparation
Collagen gels were prepared according to a protocol of T.
Ebendal [16], with slight modifications. Briefly, 455 mlo f1 0 6
MEM (Gibco), 112 ml of NaHCO3 (7.5%) (Gibco) and 50 mlo f
glutamine (200 mM) (Gibco) and 383 ml of 0.15- 1 M NaOH
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28692(Roth) were prepared as a concentrated medium. 210 ml of this
concentrated medium were gently mixed with 800 ml of a dialyzed
collagen stock solution, prepared from rat-tails. 50 ml of this
mixture were applied to cell culture wells (96 well plates, Nunc)
and maintained in cell culture incubator (37uC, 5% CO2 and
humid conditions) until a solid matrix was assembled.
Mice and tissue preparation
Time pregnancy matings of NMRI and s100 GFP mice were
performed overnight with the day of the vaginal plug in the
morning considered as day 0.5. At embryonic day 16.5 (E16.5) or
18.5 (E18.5) respectively, mothers were sacrificed by cervical
dislocation and the embryos were harvested by cesarean section.
In addition, time pregnant mice were ordered from Charles River
(matings performed over day). NRG1 type III heterozygous mice
[17] were crossbred for 3 nights. Embryos were harvested for
SCG-dissection between E16.5 and E18.5 according to the same
protocol as the NMRI mice. Genotyping of genomic DNA was
performed using Chr8 sense Primer: 59-ACTTTCTTCTTCC-
CATTCTGT -39, Chr8 antisense Primer: 59-TTTCTCTTGAT-
TCCCACTTTG -39 and NEO antisense Primer: 59-TTTA-
CTCTTCCTTACGGTCTA -39.
Superior cervical ganglia (SCGs) of the embryos were dissected,
consecutively cleaned in DPBS (Gibco) and placed on collagen
gels.
Cell culture experiments and treatments
SCGs on collagen gels were kept in serum free Neurobasal cell
culture medium containing glutamine (2 mM), B27 (16) and PSN
(penicillin/streptomycin/neomycin) (16) under humid conditions
in 37uC and 5% of CO2. SCG explants of E16.5 and E18.5
embryos showed the same characteristics under culture conditions.
All experiments were carried out under presence of nerve growth
factor (NGF, R&D, stock in PBS with 0.1% BSA: 50 ng/ml,
working concentration: 30 ng/ml) to facilitate optimal nerve
growth from the SCG explants into the collagen gel matrix. In
addition to NGF, EGFR/ErbB-2/ErbB-4 inhibitor (ErbB inhib-
itor/ErbB-inh)(Calbiochem, stock in DMSO: 4 mg/ml, working
concentration: 0.8 ng/ml) was used to inhibit ErbB signaling at
the level of the receptor (ErbB2/4). Experiments with the ErbB
inhibitor were carried out in different variations. In the first
variant the inhibitor was added at DIV (Day in vitro) 0 and the
experiment duration was either until DIV5 or until DIV8, in the
latter case with change of medium at DIV4. In the second variant
the inhibitor was added at DIV4/5 and the duration of the
experiments were until DIV9/10. For the third variant the
inhibitor was added at DIV3 with the experiment being
terminated at DIV4. In an additional set of experiments an
inhibitor of apoptosis, a caspase inhibitor (casp-inh, Caspase
inhibitor Z-VAD-FMK, Promega, 20 mM stock) was co-applied
with the ErbB-inhibitor at a concentration of 40 mm. Where
indicated Bromodeoxyuridin (BRDU 1:500, Fluka/Sigma) was
added to the medium for the last 6 hours of the experiment.
Experiments with Neuregulin 1 type III deficient SCGs were
performed for 6 days with time lapse imaging throughout the
whole period.
Time-lapse imaging and supplementary movie files
Where stated, SCG explants were imaged in near live time. The
time-lapse movies were recorded with the following frame rates.
Movie S1 with 10 minutes, movie S2 with 30 minutes, movies S3
and S4 with 10 minutes, movies S5, S6, S7, S8, S9, S10 with
10 minutes and movies S11 and S12 with 20 minutes. Files were
assembled with jepg compression via ImageJ software (scale
bars=100 mm). Time-lapse imaging was performed with a Leica
time-lapse imaging setup LASAF6000 and a Nikon time-lapse
imaging setup (Nikon Imaging Center Heidelberg). The tissue was
meanwhile incubated under humid conditions, 5% of CO2 and
37uC.
Image analyzes, quantification and statistical evaluation
For quantitative analyses of distances from the last SC to the
axonal tip and the proliferation index after ErbB-inh treatment
(BRDU/DAPI) the explants were cryosectioned and sampled. For
measuring distances 18 control and 18 ErbB-inh treated SCG
explants were used for estimation of the proliferation index 19
control and 18 ErbB-inh treated explants. For quantification of the
distance from the SCG explant to the furthest migrated SC and
the axonal length, explants were processed as whole mounts. To
facilitate optimal conditions for image acquisition with subsequent
measurements, the whole mount SCG explants were dried on
microscope slides. Distances and lengths were measured from the
explants to the periphery. For quantification of migration distances
in the case of ErbB-inh/Casp-inh cotreatment 21 control and 20
inhibitor treated ganglia were analyzed. For quantification of
Tunel positive vesicles after ErbB-inh/Casp-inh cotreatment 4
control and 5 treated ganglia were analyzed.
For quantification of migration distances after ErbB-inh
treatments, 23 inhibitor treated and 22 control explants were
used, for quantification of the axonal length 12 control and 12
ErbB-inh treated explants. Migration distances after aphidicolin
were quantified by using 12 control and 12 aphidicolin treated
explants. For quantification of apoptosis, 9 control and 8 ErbB-inh
treated explants were used and for quantification of proliferation
after aphidicolin treatment before imaging, 4 control and 8
aphidicolin treated explants. For both latter analyses whole
mounts were sampled. Distances and cell counts were performed
software based, using the NIH software ImageJ. Separate SCG
explants were taken as separate experiments for statistical
evaluation. Statistical data analyzes were performed by t-tests
using Graph Prism software (Graphpad.com).
Immunohistochemical analyzes
Explant containing collagen gels were fixed with 4% PFA at the
end of an experiment, where indicated, and either further
cryoprotected in 30% sucrose solution over night with consecutive
free floating cryosectioning (80–120 mm thickness freezing micro-
tome) (Reichardt- Jung) or directly taken for whole mount
processing.
Immunohistochemistry, using standard protocols for antibodies
against TH (Chemicon, rabbit, polyclonal, 1:1000–2000, mouse
anti-TH, 1:400) S100 (Sigma, mouse, monoclonal, 1:100) pHH3
(Milipore, rabbit polyclonal, 1: 400) was performed. Briefly,
sections were blocked in PBS containing 10% normal donkey
serum and 2% Triton6100 for 2 hours with consecutive antibody
incubation in blocking solution over night. The next day, after
washing, the sections were incubated with labeled secondary
antibodies (donkey anti rabbit/donkey anti mouse/FITC/
Alexa488/CY3). Further, sections were mounted on gelatine
coated microscope slides and air-dried. In the end nuclear
counterstaining (DAPI, 1:10000) was performed for 5 minutes
with consecutive washing and mounting in aqueous mounting
medium (DAKO/Mowiol). Explants used for whole mount
immunohistochemistry were dried on microscope slides, for best
analyses in two dimensions. Images were taken by either
conventional fluorescence microscopy with Zeiss and Olympus
microscopes or with confocal microscopy with a Leica confocal
SPE. BRDU Immunohistochemistry was performed with an
Nrg1 III/ErbB Crucial for Axonal SC Colonization
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manufacturers recommendations with slight variations. Briefly,
sections were incubated in 1N HCL 10 min on ice, in 2N HCL
10 min at room temperature and 10 min at 37uC followed by
incubation in 150 mM borate buffer (pH 8,4). Blocking was
performed with 10% NDS (Normal Donkey Serum) and 2%
Triton X-100 in PBS for 1.5 hours. The following steps were
according to standard immunohistochemistry, mentioned above.
Tunel stainings were performed according to manufacturers
description (Dead End Fluorometric Tunel System, Promega)
with slight adjustments owing to whole mount stainings.
RT-PCR
For RT-PCR, SCG tissue, explanted at embryonic day 16,
harvested at DIV3 was taken. RNA was isolated according to a
standard protocol and reversely transcribed. PCR for Neuregulin
1 subtypes was performed with the following forward primer, for
Neuregulin 1 type I: GCCGAAGGCGACCCGAGC, for Neur-
egulin 1 type II: ACAGCAGGTACATCTTCTTCATGGA and
for Neuregulin 1 type III: TCAGGAACTCAGCCACAAACAA-
CAG, combined with the reverse primer: TTTTGCAGTACGC-
CACCACACACAT respectively. Adult wildtype cortex (ctx) was
used as positive control.
Results
Time lapse imaging of Schwann cell migration along
sympathetic axons
To analyze SC migration, explants of embryonic (E16–18.5)
mouse superior cervical ganglia (SCGs) were grown on a collagen
matrix (Fig. 1E). In the presence of NGF (30 ng/ml), axons
elongate from the SCG explants into the matrix (Fig. 1A, F, G, H),
followed by a wave of migrating cells from the ganglion towards
the periphery (Fig. 1B, movie S1). Penetration of axons into the
matrix can be appreciated in the 3D reconstruction performed
with a confocal z-stack scan (Fig. 1 G, H, movie S13). For time
lapse imaging also a transgenic mouse line was used in which SCs
and SC precursors were marked by GFP expression under control
of the human S100 promoter [18] (movie S1 and S6).
Furthermore, by immunostaining for S100, migrating cells were
identified as S100-positive SCs (Fig. 1 B, C and D). Thus, this
assay has two major advantages. First, it models in vivo SC
migration along outgrowing axons. Second, it is accessible to time
lapse imaging (movie S1, S2, S5, S6). These features demonstrate
the experimental power of the SCG explant assay compared to
other SC migration assays frequently used in mouse or other
rodents.
ErbB inhibition prevents colonization of distal axonal
compartments
ErbB signaling was shown to be active during SC development
in the somatic peripheral nervous system [19]. Thus, we wanted to
address whether ErbB signaling is also relevant for SC develop-
ment in the sympathetic nervous system. To this end, we blocked
ErbB signaling with a pan-specific ErbB inhibitor (ErbB-inh,) [20].
Numerous SCs can be seen migrating along axons in solely NGF-
treated SCG explants (movie S3). In contrast, only bare axons are
visible when explants are additionally treated with the ErbB-inh
starting at DIV0 (movie S4). Interestingly, when kept in culture for
a long period (until DIV5/DIV8) SCs can be found again
migrating along axons. This indicates that the ErbB-inh when
added at DIV0 is not killing the entire pool of SC precursors
within the ganglion. To analyze whether inhibition of ErbB
signaling can block the migration of SCs that have already
colonized sympathetic nerves, ErbB-inh treatment was started
with a delay following a pretreatment with NGF only. Traveling
distances of SCs were quantified by measuring two parameters.
One parameter was the mean distance between the most distally
located axon associated SC nucleus and the tip of the axon
(scheme, Fig. 2B). The second parameter was the mean distance
from the SCG explant to the most distally localized SC (scheme,
Fig. 2D), which reflects the distance SCs have migrated. The
distance from the most distally localized SC nucleus to the tip of
the axon is increased dramatically after ErbB-inh treatment (3.5
fold) compared to the controls. Also SC nucleus-free axonal
regions were seen after Erb-inh treatment, ranging from 130–
370 mm. To determine migration distances, SCG explants were
treated with ErbB-inh at DIV3 until the assay was terminated at
DIV4. The mean distance of the furthest SC nucleus to the
explant (Fig. 2D and E) was measured. Importantly, after ErbB-
inh treatment the mean distance from the margin of the explant to
the most distal SC (Fig. 2D/E) was reduced to 70%, compared to
Figure 1. Schwann Cell Migration Assay using NGF induced
axon outgrowth from SCG explants. SCG explants derived from
mouse E16–E18 were cultured on collagen gels and treated with NGF
(30 ng/ml). A: Overview, immunohistochemistry for TH (green) with
DAPI nuclear counterstaining, explant at DIV4 (scalebar=500 mm). B:
Overview, immunohistochemistry for S100 (red) explant at DIV4
(scalebar=200 mm). C/D: Immunohistochemistry for TH (green) with
nuclear counterstaining DAPI (blue). Clear (red) S100 positive cells are
attached to the TH positive axons (arrows). (scalebar=50 mm) Note that
after sectioning and performance of immunohistochemistry, Schwann
cells can also be found close to the axonal endings.
doi:10.1371/journal.pone.0028692.g001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28692Figure 2. ErbB signaling is important for Schwann cell migration. A: Immunohistochemistry (DIV9/10), TH (green) and DAPI (blue) of an NGF
treated control (ctr) and and NGF/ErbB-inh treated (starting DIV4/5) sample (scale bars=50 mm). Ctr: NGF treated SCG explant, ErbB-inh: combined
NGF and ErbB-inh treated SCG explant (E16.5). Note the presence of SC nuclei in the proximity to the axonal endings (arrowheads) in the control,
whereas in the ErbB-inh treated probe large uncovered areas are visible (asterisks). B: scheme showing the first method for quantification of the
distance between the distal Schwann cell nucleus and the axonal tip. C: Quantification of the distances between the distal SC nucleus and the axonal
tip. Quantification has been performed for inhibitor treatments starting at DIV4/5 (t-test: p value,0,0001). Distances are given in percentage to the
respective NGF treated controls which are set as 100%. Graphs are presented as mean and +/2 SEM. Note the drastic increase of the distances. D:
Scheme showing the second method for quantification of distances between SCG explants and SC nuclei treated from DIV3 to DIV4 on. E:
Quantification of mean distances between SCG explant and the furthest SC nucleus. (t-test: p value,0,0001). The solely NGF treated controls were set
to 100%. Graphs are presented as mean and +/2 SEM. F: TH immunohistochemistry (green) of a control and a ErbB-inh treated sample. G:
Quantification of axonal lengths between ctr and ErbB-inh treated samples. The mean axonal length of the control was set to 100%. (t-test: p
value=0.3105) Graphs are presented as mean and +/2 SEM.
doi:10.1371/journal.pone.0028692.g002
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receptors slows SC colonization of distal axonal compartments.
Importantly, axonal length might be influenced by SCs or itself
influencethe distancesbetween the leadingSCs, the explant and the
axonal tip. To this end, TH-ir positive axons were measured from
the border of explants to the periphery at DIV4 after treatment with
the ErbB-inhat DIV3. When compared to controls only a very mild
increase in axonal length was observed (Fig. 2F/G).
ErbB signaling promotes SC proliferation
Since proliferation and survival of SCs may affect their
migraton, we asked whether ErbB signaling affects SC mitosis.
Thus, we employed a delayed treatment of SCG explants (DIV4/5
until DIV9/10) with ErbB-inh and added BRDU to the culture
medium for the last 6 hours of the experiment. For quantitative
analysis the explants were cut and immunostained for TH and
BRDU combined with a DAPI nuclear counterstaining (Fig. 3A).
When we determined the BRDU/DAPI proliferation ratio
(Fig. 3B) we observed a reduction to less than 50% in the ErbB-
inh treated explants. To address whether proliferation and
migration functionally interact, we aimed at uncoupling both
processes. To this end we used Aphidicolin, a cytostatic drug,
which retains cells in the early S phase of mitosis by blocking DNA
polymerases [21]. The impact of Aphidicolin on SC proliferation
was directly validated by immunostaining for phosphorylated
histone 3 (pHH3), a marker for cell mitosis. Quantification showed
a massive reduction of pHH3-positive axon associated SCs (Fig. 3
C/D). We want to note that even though Aphidicolin acts as a
cytostatic drug we observed dead SC nuclei, especially after a
longer treatment over two days. es S7/S7a show explants treated
Figure 3. ErbB signaling is affecting Schwann cell proliferation. A: delayed treatment of SCG explants (starting at DIV4/5) and additionally
analyses of BRDU incorporation. Immunohistochemistry, TH (green), BRDU (red) and DAPI (blue) of control (ctr) and ErbB-inh treated (ErbB-inh)
samples. Whereas in the control many nuclei (DAPI/blue) are also positive for BRDU (red) (arrowheads), in the ErbB-inhibitor treated sample there are
only very few nuclei positive for BRDU (arrowhead). B: Analysis of the DAPI/BRDU ratio. After treatment with ErbB-inh SC proliferation is decreased
drastically. T-test: p-value=0,0001. Graphs are presented as mean and +/2 SEM. C: Immunohistochemistry TH (green), phH3 (red) and DAPI (blue).
Control (ctr) Aphidicolin (Aph), note the difference in the number of phH3 positive cells. D: Analysis of the proliferation index (pHH3/DAPI). B:
Quantification of proliferation index (pHH3/DAPI) (t-test: p value,0,0001) Graphs are presented as mean and +/2 SEM. E: DAPI nuclear staining of a
control (ctr) and a Aphidicolin (Aph) treated sample. F: Quantitative analyses of migration distances between control and Aphidicolin treated sample.
(t-test: p value=0.0062) Graphs are presented as mean and +/2 SEM. Note that a mild reduction of the migration distance is visible after Aphidicolin
treatment.
doi:10.1371/journal.pone.0028692.g003
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observed, in Aphidicolin treated explants (movie S5/S6),
whereas directed SC migration was halted after a treatment
with ErbB-inh (movie S7/S8, see movies S5 and S6 as controls).
However, although SC migration was not blocked by Aphidi-
colin treatment (movie S9/S10), migration distance was
modestly reduced (Fig. 3 E/F).
ErbB signaling affects SC migration indirectly
To address the effect of ErbB inhibition on SC apoptosis,
explants were analyzed by Tunel staining and quantification of
apoptotic vesicles in sampled areas. A dramatic increase of
apoptotic vesicles in ErbB-inh treated samples compared to
controls (Fig. 4A) was observed. To investigate whether increased
cell death affects the migratory potential of the surviving SC pool,
we employed a combined delayed treatment with the ErbB-inh
and a Caspase inhibitor (Casp-inh) to block apoptosis. The anti
apoptotic activity of the Casp-inh was estimated by Tunel staining
and quantification of apoptotic vesicles in sampled areas in
comparison to control explants. The Casp-inh applied in
combination with the ErbB-inh significantly reduced apoptosis
(Fig. 4B) to levels comparable to controls. Surprisingly however,
after blocking both ErbB signaling and apoptosis, no difference in
migration distances could be observed (Fig. 4C) when compared to
control explants. This suggests an indirect negative effect of ErbB
inhibition on SC migration and colonization of distal axonal
compartments.
The type III variant of NRG1 is crucial for SC colonization
Multiple NRG1 isoforms are produced by alternative splicing
and grouped into three subclasses according to the presence of
distinct N- terminal domains [22]. We examined which of these
isoforms may act upstream of glial ErbB receptors during SC
migration in the sympathetic nervous system. To identify NRG1
isoforms expressed in SCGs during development, RT-PCR was
performed on SCG RNA prepared at DIV3 from SCGs explanted
at E16.5. SCGs displayed prominent NRG1 type III expression,
whereas type I was only weakly expressed and type II virtually
absent (Fig. 5A). We therefore analyzed SC migration in SCG
explants derived from NRG1 type III deficient mice and control
littermates (E16.5–18.5). In NRG1 type III-deficient SCG explants
normal axonal outgrowth was detected (Fig. 5 B–E, movie S12,
ctr: movie S11).
In contrast, we observed a strongly reduced number of
migrating SCs along elongating axons of NRG1 mutants when
compared with control explants (Fig. 5 B–E). As a result we
observed SCs in proximal regions (Fig. 5 F–K), but distal regions
of NRG1 type III mutant axons almost completely lacked SCs
(Fig. 5 F–H), with only a few exceptions (Fig. 5 I/K). We conclude
that axonal NRG1 type III is required for the SC colonization of
distal compartments of sympathetic axons.
Discussion
A more detailed understanding of the molecular mechanisms
that regulate SC development has been hampered by methodo-
logical restrictions. Many studies to date used ‘‘Boyden assays’’ or
‘‘Scratch assays’’ to analyze SC migration. Here, we employed a
SC migration assay, which has been adapted from the classical
ganglion explant technique [14]. This assay more closely mimics
development in vivo, as it contains axons the physiological
substrates for SC migration and allows SC migration out of an
explanted SCG along outgrowing axons to the periphery. Only
few others have used similar approaches [9,15].
We identify signaling by ErbB receptor tyrosine kinases as a
major regulator of SC development in the sympathetic nervous
system with respect to SC proliferation, survival and colonization
of distal axonal areas. Pharmacological blockade of ErbB2/4
potently reduced SC proliferation and induced apoptosis.
Figure 4. ErbB inhibition interferes with SC migration indirect-
ly. Quantitative analyses of Tunel positive vesicles of NGF treated
control versus ErbB-inh treated samples (t-test: p value,0.0001). Graphs
are presented as mean and +/2 SEM. A strong increase in Tunel positive
vesicles is visible in the ErbB inhibited explants. B: Quantitative analyses
of Tunel positive vesicles after a combined treatment with ErbB-inh and
Casp-inh (t-test: p value=0.8553). Graphs are presented as scatter blot
with mean. Note that the Casp-inh potently inhibits apoptosis. C:
Quantitative analyses of migration distances after a combined
treatment with ErbB-inh and Casp-inh (t-test: p value=0,2706). Graphs
are presented as scatter blot with mean to also show the inner group
variance.
doi:10.1371/journal.pone.0028692.g004
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severely affected by ErbB inhibition as demonstrated by time-lapse
imaging as well as by quantification of migration distances.
To address the different phenotypes observed and to investigate
how these phenotypes interact, we employed several assays, in
which we pharmacologically uncoupled ErbB signaling from SC
proliferation and survival. The massive SC migration out of an
explant (movies S1/S2) indicates that proliferation is necessary to
provide the large number of migrating cells. However, since
inhibition of SC proliferation (without blocking ErbB signaling)
did not prevent migration (movies S9/S10) and only mildly
affected the colonization of distal axonal compartments in the
investigated time frame, we propose that SCs can migrate along
sympathetic axons in the absence of cell division, similar to
findings in the peripheral nervous system of zebrafish [13].
Furthermore, we investigated the interplay between SC apoptosis
and migration. Unexpectedly, while the inhibition of ErbB
signaling severely affected the migration of SCs to distal parts of
sympathetic axons (Fig. 2), normal SC migration was restored
when apoptosis was blocked together with ErbB signaling. This
Figure 5. Analyzes of Neuregulin 1 type III deficient SCG explants. A: RT-PCR for Neuregulin 1 splice variants from SCG RNA. Tissue was
explanted at E16.5 and harvested at DIV3. Adult wildtype cortex was taken as positive control. Note that Neuregulin 1 type III is strongly expressed,
whereas type I is only weak and type II is almost not expressed. B–K: Confocal images (scalebar 100 mm) B–E: Immunostainings of control explants, TH
(green), s100 (red) with DAPI nuclear counterstaining (blue), D: close up of boxed area in C, nuerous SCs can be seen in proximity to axonal tips
(arrows). F–K: Immunostainings of Nrg1 typeIII- KO explants, TH (green), s100 (red) with DAPI nuclear counterstaining (blue), G: close up of boxed area
in F, SCs can be seen almost exclusively in proximal regions (F, G and H) with only few exceptions (arrows in L and M).
doi:10.1371/journal.pone.0028692.g005
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the migration of SCs along sympathetic axons and is at odds to
studies in zebrafish [13]. However, since previous studies have
shown that much lower levels of ErbB signaling are required to
promote SC migration compared to proliferation [10], we cannot
exclude the possibility that residual ErbB activity persists in our
explant assay after pharmacological treatment, which might be
sufficient to restore migration when massive SC apoptosis is
blocked. Also other factors could compensate when ErbB signaling
is blocked but Schwann cell survival is maintained. Potential
candidates for this, also shown to influence SC motility, are GDNF
[11] NGF [23] and IGF-1 [24].
Finally, we provide data, which suggest the splice variant NRG1
type III, as the major axonal ligand for ErbB receptors to promote
SC colonization of sympathetic axons. Meyer et al [25] suggested
this splice variant to be expressed in sympathetic ganglia at E12.
Here we show that NRG1 type III continuous to be expressed at a
late embryonic stage. Migration assays using NRG1 type III-
deficient SCG suggested an essential role of NRG1 type III for the
directed migration of SCs along sympathetic nerves. Since a
reduced number of SCs persists in the proximity of explanted
NRG1 type III-deficient sympathetic ganglia, we argue that
impaired migration cannot be explained solely by the loss of
(premigratory) SCs. Findings in NRG1 type III null mutants from
a previous study [17] also demonstrated a lack of SCs in distal
areas of peripheral nerves. Reduced SC numbers in distal axonal
areas were explained by impaired proliferation and increased
apoptosis of SCs in the absence of NRG1 signaling, which acts as a
SC mitogen and survival factor in vitro [4,26,27].
However, this interpretation does not fully explain, why in our
study SCs are present in the vicinity of explanted ganglia but fail to
colonize distal areas. Considering our data regarding ErbB
receptor blockade, it is conceivable that reduced survival in the
proximal regions of axons leads to stalling or even backward
movement of viable migrating SCs, which would indirectly impair
the colonization of distal axonal compartments. Aberrant
migration (including ‘backward’ movement) has been observed
after pharmacological blockade of ErbB signaling in zebrafish
[13]. A reason for not observing large amounts of dead SCs along
NRG1 typeIII deficient axons as we did after ErbB blockade could
be due to the experimental setup. Interfering with ErbB signaling
of migrating wildtype SCs was performed at DIV3 and led to
massive SC death. In the other experimental setup, NRG1 typeIII
was genetically depleted and absent from the start of the
experiment. Therefore a steady state could have been adjusted
earlier. In addition, ErbB inhibition led to reduced proliferation.
Although SCs were able to migrate in general when cell division
was blocked, a reduced proliferation from the beginning of the
experiment could lead to a massively reduced number of SCs.
Finally we propose that due to reduced proliferation and survival
the few SC in the vicinity of NRG1 type III KO SCG explants
rather stall than migrate to distal compartments.
In summary the SCG explant culture is a powerful tool to
investigate SC development. We used this assay and characterized
the role of NRG1/ErbB signaling for SC proliferation, apoptosis
and colonization of distal axon compartements during peripheral
sympathetic axon development.
Supporting Information
Movie S1 S100-GFP (E17.5), imaging start DIV2, until DIV3.
(AVI)
Movie S2 NGF treated (E18.5), imaging start DIV1, imaging
duration 2 days.
(AVI)
Movie S3 Control to ErbB-inh (E16.5) movie 4, imaging start
DIV2, imaging duration 2 days.
(AVI)
Movie S4 ErbB-inh (E16.5), imaging start DIV2, imaging
duration 2 days (factors added DIV0).
(AVI)
Movie S5 Ctr (E17) to movies 7 and 9, imaging DIV3–DIV4.
(AVI)
Movie S6 (E17.5) ctr to movies 8 and 10, imaging DIV3–DIV4,
arrows show direction of SC migration.
(AVI)
Movie S7 ErbB-inh (E17), imaging DIV3–DIV4 (factors added
at DIV3).
(AVI)
Movie S8 (E17.5) ErbB-inh, imaging DIV3–DIV4 (factors
added at DIV3), arrows show direction of SC migration.
(AVI)
Movie S9 Aphidicolin (E17), imaging DIV3–DIV4 (factors
added at DIV3).
(AVI)
Movie S10 (E17.5) Aphidicolin, imaging DIV3–DIV4 (factors
added at DIV3), arrows show direction of SC migration.
(AVI)
Movie S11 Neuregulin 1 type 3-ctr (E16–18.5) to movie 12,
imaging start DIV0, duration for 6 days.
(AVI)
Movie S12 Neuregulin 1 type 3-KO (E16–18.5), imaging start
DIV0, duration for 6 days.
(AVI)
Movie S13 3D reconstruction of a confocal z-stack of an control
explant.
(AVI)
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